AHPAC and AZ: NON CME Cardio-Renal Benefits and Clinical Implementation of Dapagliflozin
Posted about 2 years ago by Camille Dyer
The Cardio-Renal Benefits and Clinical Implementation of Dapagliflozin.
Goal: To integrate research, science, and the art of clinical practice to optimize reductions in hospitalizations for HF and CKD progression
Speakers: Maria O’Connor PA-C, RD, DCES, Deidre Edwards, Pharm. D. and Ima Vanderpool, DNP, AGPCNP-C
Date: February 01, 2022
Time: 8:00 p.m. ET
Please email ahpacmembership@gmail.com if you are interested in participating.